Depot buprenorphine is a new pharmacotherapy that represents a significant development in the model of care for patients with opioid dependence, with two depot products now available for use in Australia.
You can now access a free, online, short course designed to support prescribers and other health professionals in providing depot buprenorphine treatment in a safe and effective manner.
To get started, visit www.otac.org.au to create an account and complete the short course.
Other educational activities available include modules on the fundamentals of opioid treatment in NSW, driving safety considerations for opioid treatment patients, and the Opioid Treatment Accreditation Course (OTAC).
To find out more, visit the website or contact otac.info@sydney.edu.au